May 15, 2025 - 23:54

A recent study led by researchers at Stanford University has shed light on the genetic factors behind the distinctive orange fur seen in many cats. The investigation revealed a mutation located on the X chromosome that plays a crucial role in determining coat color. This specific mutation activates the normally dormant Arhgap36 gene within pigment cells, which in turn inhibits the production of black and brown pigments.
The findings suggest that this genetic alteration is responsible for the vibrant orange hue that characterizes many feline companions. By blocking the synthesis of darker pigments, the mutation allows the lighter orange tones to dominate. This discovery not only enhances our understanding of feline genetics but also raises intriguing questions about the relationship between genetics and behavior in these beloved pets.
As researchers continue to explore the implications of this mutation, the study highlights the complex interplay between genetics, color, and potentially chaotic behaviors often associated with ginger cats. This breakthrough could pave the way for further investigations into the genetic underpinnings of coat color in various animal species.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...